Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one

Home/Academy/Journal Finder/The Lancet Infectious Diseases

Infectious diseases

The Lancet Infectious Diseases

The Lancet Group (Elsevier)

Clinical and public health research, reviews and commentary on infectious diseases, including trials, antimicrobial resistance, vaccines and global health.

ISSN 1473-3099 (print)ISSN 1474-4457 (online)Licence Gold open access: CC BY or CC BY-NC-ND (the open access section also names CC BY-NC; confirm, and check the funder's preferred licence)Access Hybrid (subscription, with gold or green open access for eligible research Articles)
Hybrid (subscription, with gold or green open access for eligible research Articles)Publishing model
Verified 2026-11Field-level — see each tab
CiteScore39.2 2025 · Scopus, as listed on the journal's about page
Impact Factor29.4 2025 · JCR (Clarivate), as listed on the journal's about page
QuartileQ1 2025 · JCR (Clarivate) category rank, Infectious Diseases
Article Fee (APC)$8,810 (optional OA) 2026 · publisher open access page
First DecisionNot disclosed by publisher
Acceptance RateNot disclosed by publisher

Overview

The Lancet Infectious Diseases is published by The Lancet Group (Elsevier). Clinical and public health research, reviews and commentary on infectious diseases, including trials, antimicrobial resistance, vaccines and global health.

Key information

PublisherThe Lancet Group (Elsevier)
ISSN (Print)1473-3099
ISSN (Online)1474-4457
Publishing modelHybrid (subscription, with gold or green open access for eligible research Articles)
CountryUnited Kingdom
FrequencyMonthly (Volume 26, Issue 11 is November 2026)
Subject categoryInfectious diseases
EditorUrsula Hofer (Editor-in-Chief), The Lancet Group, London, UK
Established2001
SubmissionsNot disclosed by the publisher; neither The Lancet nor Elsevier publishes annual submission counts

Editor, scope, metrics, indexing, fees and policies are from the journal's Lancet Group pages (aims and scope, Information for Authors of August 2026, submission guidelines, content types, open access, formatting guidelines and article templates), read November 2026. Submission volume is not published.

Aims & scope

The Lancet Infectious Diseases publishes original research that advocates change in or illuminates infectious disease clinical practice, and informative reviews on any topic connected with infectious diseases and human health. Topics include, but are not limited to:

  • Anti-infective therapy and immunisation
  • Bacterial, viral, fungal and parasitic infections
  • Emerging infectious diseases
  • HIV/AIDS, malaria, and tuberculosis and mycobacterial infections
  • Infection control
  • Infectious diseases epidemiology
  • Neglected tropical diseases
  • Travel medicine

The journal prefers articles likely to influence clinical practice or thinking. It also publishes Series and Commissions intended to shape clinical practice and health policy in areas of need in infectious diseases.

Reporting guidelines accepted

CONSORT 2025 (randomised trials)PRISMA (systematic reviews, meta-analyses)STROBE (observational studies)STARD (diagnostic accuracy)ORION (infection control, outbreak reports)STROME-ID (molecular epidemiology)STREGA (genetic association studies)COREQ or SRQR (qualitative studies)GATHER (global health estimates)MIAME (microarray papers)

Verified against the journal's Lancet Group pages (Information for Authors, August 2026; open access and formatting guidelines), read November 2026, and PubMed records for the sample articles.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.